Physician

Trevor J. Pearson, MD

According to 2025 Medicare claims, Trevor Pearson, MD (NPI: 1639123516) practices gastroenterology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is MIDWEST GASTROINTESTINAL ASSOCIATES PC (NPI: 1073569125; TIN: 470772952) and primary practice location at 68130-4670. Pearson is affiliated with the Nebraska Health Network, LLC (ACO ID: A3273), NPG Health Collaborative LLC (ACO ID: A3287), Bryan Health Connect ACO, LLC (ACO ID: A4573), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Pearson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 666 traditional Medicare patients, billed 21,784 HCPCS/CPT codes, and received $424,530 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,947 prescription claims across 516 beneficiaries totaling $939,299 in drug costs, led by Stelara (Ustekinumab). Open Payments data shows 121 records totaling $4,371. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $212,287 to $424,530. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $136,838 to $939,299. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	679	2,568	$212,287
2016	661	4,616	$200,745
2017	755	10,337	$314,513
2018	764	10,511	$318,181
2019	705	9,709	$352,014
2020	643	9,696	$300,753
2021	733	17,562	$483,473
2022	707	12,690	$317,897
2023	708	15,687	$365,334
2024	666	21,784	$424,530

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	304	1,077	$136,838
2016	341	1,175	$306,736
2017	402	1,362	$209,994
2018	406	1,458	$161,931
2019	444	1,478	$356,239
2020	444	1,561	$261,612
2021	441	1,519	$373,113
2022	455	1,546	$666,947
2023	472	1,654	$887,655
2024	516	1,947	$939,299

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	185	185	$186
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	63	63	$162
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	46	46	$93
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	109	110	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	110	146	$52

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	18	1,008	$490,154
Linzess	Linaclotide	49	1,890	$34,288
Movantik	Naloxegol Oxalate	40	1,242	$17,273
Mesalamine	Mesalamine	34	2,360	$13,004
Mesalamine Er	Mesalamine	49	2,420	$12,087

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	121	$4,371	AIMMUNE THERAPEUTICS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Trevor J. Pearson, MD?

Tedicare shows public-source Medicare data for Trevor J. Pearson, MD (NPI 1639123516), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Trevor J. Pearson, MD have ACO affiliation data?

Trevor J. Pearson, MD is shown with ACO affiliation data for Nebraska Health Network, LLC (MSSP, ACO ID A3273), NPG Health Collaborative LLC (MSSP, ACO ID A3287), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Trevor J. Pearson, MD?

Trevor J. Pearson, MD is linked to MIDWEST GASTROINTESTINAL ASSOCIATES PC (billing NPI 1073569125) in the available physician profile data.

Does Trevor J. Pearson, MD have Open Payments data?

Trevor J. Pearson, MD has 121 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.